Skip to content

Advertisement

  • Letter
  • Open Access

Hyperoxia effects on intensive care unit mortality: a retrospective pragmatic cohort study

  • 1Email author,
  • 1, 2, 3,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1, 2,
  • 1, 2,
  • 1, 2 and
  • 1
Critical Care201822:218

https://doi.org/10.1186/s13054-018-2142-6

  • Received: 18 July 2018
  • Accepted: 30 July 2018
  • Published:

Supplementary oxygen is frequent in the management of patients admitted to the intensive care unit (ICU) [1]. However, some studies have suggested deleterious effects of hyperoxia on these patients [24]. This main study objective was to assess the association between hyperoxia, at any time of the ICU stay, and ICU mortality regardless of the cause of patient admission.

Our study was an observational, retrospective, and single-centre study in the Hôpital Européen George Pompidou medical ICU, Paris, France. All patients admitted between November and December 2017 were included regardless of their admission cause and all of their arterial blood gases (ABGs) were analysed. Hyperoxia was defined as a partial arterial pressure in oxygen (PaO2) superior to 100 mmHg (13.3 kPa). The principal judgement criterion was occurrence of at least one hyperoxia episode during the ICU stay. All statistical tests were two-tailed with a significance threshold of 0.05. Analyses were performed with R v3.2.4. Survival analysis was estimated by Kaplan–Meier methods.

A total of 130 patients, median age 68 (57–79) years and median SAPS II 45 (35–56), were included. The mean reason for ICU admission was respiratory failure (60 patients, 46%) and 83 patients (64%) needed mechanical ventilation. Thirty-five patients (27%) died during their ICU stay.

Eighty patients (62%) presented at least one episode of hyperoxia. Overall survival (OS) was significantly lower in patients who presented at least one episode of hyperoxia during their ICU stay: median OS was 26 days (95% CI 20–NR) versus median not reached, p = 0.0047 (Fig. 1).
Fig. 1
Fig. 1

Kaplan–Meier estimation of overall survival. Hyperoxia group, patients who presented at least one hyperoxia episode during ICU stay. No hyperoxia group, patients who presented no hyperoxia episode during ICU stay. Overall survival median in hyperoxia group 26 days (95% CI 20–NR); overall survival median in no hyperoxia group not reached. ICU intensive care unit

In univariate analysis, hyperoxia was a risk factor for mortality: 31 deceased patients presented hyperoxia (89%) versus 49 alive patients (52%), p < 0.001. SAPS II and mechanical ventilation time were also mortality risk factors in univariate analysis (Additional file 1: Table S1). Multivariate analysis showed that hyperoxia was an independent risk factor for ICU mortality: OR = 3.80 (95% CI 1.08–16.01), p = 0.047 (Table 1).
Table 1

Mortality risk factors in the medical ICU, multivariate analysis

Mortality risk factor

Deceased (n = 35)

Alive (n = 95)

Odds ratio (95% CI)

p

Age (years)

70 (66–75)

65 (61–69)

 

0.15

SAPS II

64 (56–72)

41 (37–45)

 

< 0.001

Mechanical ventilation time

9 (7–12)

5 (3–7)

 

0.074

At least one PaO2 > 100 mmHg (13.3 kPa)

31 (89%)

49 (52%)

3.80 (1.08–16.01)

0.047

Data presented as mean (95CI) or n (%)

R2 = 0.453

CI confidence interval, ICU intensive care unit, PaO2 partial arterial pressure in oxygen, SAPS II Simplified Acute Physiology Score II

Despite a conservative oxygen policy, 62% of patients presented at least one episode of hyperoxia, which reinforces the statement by Helmerhorst et al. [5]. Previous studies had a focus on specific categories of selected patients [24]. On the contrary, our study is a pragmatic study in real-life conditions. We included all consecutive patients admitted to the medical ICU without any exclusion criteria, regardless of the admission cause, mechanical ventilation need, or initial severity, and we collected prospectively a large amount of 1.450 ABG. In this study, we demonstrated that hyperoxia at any time of the ICU stay significantly decreases OS and is an independent mortality risk factor.

Abbreviations

ABG: 

Arterial blood gas

ICU: 

Intensive care unit

OS: 

Overall survival

PaO2

Partial arterial pressure in oxygen

SAPS II: 

Simplified Acute Physiology Score II

Declarations

Availability of data and materials

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

MR participated in data acquisition, data analysis, and data interpretation, wrote the manuscript, and created Fig. 1. EG designed the study and revised the manuscript. CB and NA participated in the study and designed and revised the manuscript. JN participated in data acquisition and analysis. CH-B, BH, J-LA, SO, DV, and J-LD are physicians and were involved in patient care. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Data collection and analyses were conducted in accordance with the French national guidelines: under French law, a retrospective study using data from medical charts requires only a declaration to the Commission nationale Informatique et Libertés. The hospital’s computerised database was declared at this commission. There is no requirement for declaration to an ethic committee.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Intensive Care, Hôpital européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, 20 rue Leblanc, 75015 Paris, France
(2)
Université Paris Descartes, 12 rue de l’école de Médecine, 75006 Paris, France
(3)
INSERM U970, 20 rue Leblanc, 75015 Paris, France

References

  1. Panwar R, Capellier G, Schmutz N, Davies A, Cooper DJ, Bailey M, et al. Current oxygenation practice in ventilated patients—an observational cohort study. Anaesth Intensive Care. 2013;41:505–14.PubMedGoogle Scholar
  2. Vincent J-L, Taccone FS, He X. Harmful effects of hyperoxia in postcardiac arrest, sepsis, traumatic brain injury, or stroke: the importance of individualized oxygen therapy in critically ill patients. Can Respir J. 2017;2017:1–7.View ArticleGoogle Scholar
  3. Damiani E, Adrario E, Girardis M, Romano R, Pelaia P, Singer M, et al. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care [Internet]. 2014;4(1):23. Available from: http://ccforum.biomedcentral.com/articles/10.1186/s13054-014-0711-x. Cited 2018 Jul 15.
  4. Helmerhorst HJF, Roos-Blom M-J, van Westerloo DJ, de Jonge E. Association between arterial hyperoxia and outcome in subsets of critical illness: a systematic review, meta-analysis, and meta-regression of cohort studies. Crit Care Med. 2015;43:1508–19.View ArticleGoogle Scholar
  5. Helmerhorst HJ, Schultz MJ, van der Voort PH, Bosman RJ, Juffermans NP, de Jonge E, et al. Self-reported attitudes versus actual practice of oxygen therapy by ICU physicians and nurses. Ann Intensive Care [Internet]. 2014;18(6):711. Available from: http://www.annalsofintensivecare.com/content/4/1/23. Cited 2018 Jul 15.

Copyright

© The Author(s). 2018

Advertisement